Abvc Biopharma, Inc. Liquidation Value

ABVC Other

Cash & Equivalents

$681,480
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $681,480
Total Obligations: -$8.08M
$-7.40M
Per share: $-0.30
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $681,480
AR: $0
Total Obligations: -$8.08M
$-7.40M
Per share: $-0.30
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $681,480
AR: $0
Inventory: $11,460
Total Obligations: -$8.08M
$-7.39M
Per share: $-0.29
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-7.40M$-0.30
Liquid Liquidation Value$-7.40M$-0.30
Operating Liquidation Value$-7.39M$-0.29

Key Components (as of 2025-12-31)

Cash & Equivalents$681,480
Accounts Receivable$546
Inventory$11,460
Current Liabilities$6.16M
Long-term DebtN/A
Op. Lease Liability$1.92M
Finance LeaseN/A
Shares Outstanding25.1M

Explore all 159 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$681,480N/A$11,460N/A$6.16MN/A$1.92MN/A
2025-09-30$192,068$546$11,460N/A$6.54MN/A$363,407N/A
2025-07-31$83,567N/AN/AN/AN/AN/AN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-03 View
2025-09-30 10-Q 2025-11-03 View
2025-09-30 10-Q/A 2026-03-03 View
2025-06-30 10-Q 2025-08-13 View
2025-03-31 10-Q 2025-04-30 View
2024-12-31 10-K 2025-04-15 View
2024-09-30 10-Q 2024-11-14 View
2024-06-30 10-Q 2024-08-14 View

Community Notes

Loading notes...

Questions

Loading questions...